Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129511 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL448718 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL450997 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10959408 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9366273 | 1.00 | — | — | |
| SCHEMBL135854 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL129533 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL9362653 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10959317 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL10955670 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2820054-B1 | PROCESSES FOR THE PREPARATION OF HIGH-CIS POLYDIENES | BRIDGESTONE CORP (JP) | 2017-04-05 | — | — | EP | claimed |
| CN-218539283-U | Silver protection production is with intelligent stirring and filling mixing arrangement as an organic whole | 捷泽新材料科技(苏州)有限公司 | 2023-02-28 | — | — | CN | disclosed |
| EP-2883865-B1 | Compound capable of binding S1P receptor and pharmaceutical use thereof | ONO PHARMACEUTICAL CO (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-10418607-B2 | Slurry for secondary battery porous membranes, secondary battery porous membrane, secondary battery electrode, secondary battery separator, secondary battery, and method for producing secondary battery porous membrane | ZEON CORPORATION (JP) | 2019-09-17 | — | — | US | disclosed |
| CN-103339757-B | The manufacture method of secondary cell perforated membrane slurry, secondary cell perforated membrane, electrode for secondary battery, secondary battery separator, secondary cell and secondary cell perforated membrane | ZEON CORP. (JP) | 2015-11-25 | — | — | CN | disclosed |
| EP-2883865-A1 | Compound capable of binding S1P receptor and pharmaceutical use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2015-06-17 | — | — | EP | disclosed |
| EP-1661881-B1 | COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO (JP) | 2014-12-17 | — | — | EP | disclosed |
| EP-2592066-B1 | Aminocarboxylic acid derivative and medical use thereof | ONO PHARMACEUTICAL CO (JP) | 2014-12-03 | — | — | EP | disclosed |
| EP-2371811-B1 | Azetidinecarboxylic acid derivative and medicinal use thereof | ONO PHARMACEUTICAL CO (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-20140288034-A1 | COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| EP-1826197-A1 | AMINOCARBOXYLIC ACID DERIVATIVE AND MEDICINAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-08-29 | — | — | EP | disclosed |
| EP-1815037-A1 | METHOD AND PRODUCTION LINE FOR COATING ONE FACE OF METAL STRIPS AND ASSOCIATED USE OF SAID STRIPS | WIELAND-WERKE AG (DE) | 2007-08-08 | — | — | EP | disclosed |
| US-20070167425-A1 | Compound capable of binding s1p receptor and pharmaceutical use thereof | ONO PHARMACEUTICAL CO., LTD (JP) | 2007-07-19 | — | — | US | disclosed |
| EP-1763877-A1 | OPTICAL INFORMATION RECORDING CARRIER | Fujifilm Corporation (JP) | 2007-03-21 | — | — | EP | disclosed |
| EP-1760071-A1 | COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
| US-20060227695-A1 | Recording media | FUJI PHOTO FILM CO., LTD. (JP) | 2006-10-12 | — | — | US | disclosed |
| WO-2006056346-A1 | METHOD AND PRODUCTION LINE FOR COATING ONE FACE OF METAL STRIPS AND ASSOCIATED USE OF SAID STRIPS | WIELAND-WERKE AG (DE) | 2006-06-01 | — | — | WO | disclosed |
| EP-1661881-A2 | COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005112017-A1 | OPTICAL INFORMATION RECORDING CARRIER | FUJIFILM CORPORATION (JP) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005029483-A1 | RECORDING MEDIA | FUJI PHOTO FILM CO.,LTD. (JP) | 2005-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288034-A1 | COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF | S1PR1, S1PR2, S1PR3 | FAAH 901/4885TRPV1 203/4885TSHR 546/4885 |
| US-20070167425-A1 | Compound capable of binding s1p receptor and pharmaceutical use thereof | S1PR1, S1PR3, S1PR2 | FAAH 1781/4885TRPV1 636/4885TSHR 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.